Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

mifepristone

mifepristone

21 results

Sort 21 results by:

Filter Applied. Clear All

Latest Posts

March 3, 2026 From Prevention to Prenatal Surgery: Medical Breakthroughs Are Changing the Trajectory of Spina Bifida From Prevention to Prenatal Surgery: Medical Breakthroughs Are Changing the Trajectory of Spina Bifida March 2, 2026 Testimony of Ingrid Skop, M.D., before the South Dakota Senate State Affairs Committee Testimony of Ingrid Skop, M.D., before the South Dakota Senate State Affairs Committee February 24, 2026 Testimony of CLI Associate Scholar Kathi Aultman, M.D., before the South Dakota House State Affairs Committee Testimony of CLI Associate Scholar Kathi Aultman, M.D., before the South Dakota House State Affairs Committee
Reset All Filters
featured-image
mifepristone

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

CLI's VP of Medical Affairs Ingrid Skop, together with Calum Miller, MD, and Kevin Duffy, MPH, recently published an article…

Ingrid Skop, M.D., FACOG
May 23, 2024
Please login to bookmark Close
featured-image
mifepristone

New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs

A new peer-reviewed article highlights major flaws in the data used by the U.S. Food and Drug Administration (FDA) to…

mifepristone

Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

On March 26, SCOTUS will hear oral arguments in the case FDA v. Alliance for Hippocratic Medicine. In the case,…

featured-image
mifepristone

Scientists to SCOTUS: FDA Harms Women & Doctors by Allowing Dangerous Mail-Order Abortion Drugs

As the nation’s leading pro-life scientific, statistical and research center, the Charlotte Lozier Institute has filed an amicus brief asking…

mifepristone

Induced Abortion with Misoprostol Alone

As abortion limits have been implemented in many states in the wake of the Supreme Court’s Dobbs decision, some perplexing…

mifepristone

Lozier Institute Statement on Abortion Pill Lawsuit Filed by Alliance Defending Freedom

Charlotte Lozier Institute, which in 2021 revealed a dramatic surge in abortion pill-related emergency room visits, today applauded Alliance Defending…

mifepristone

Dangerous Deception: Not Telling Your Doctor About Abortion Pill Use Increases Health Risks

A new analysis of 423,000 confirmed abortions debunks the common abortion industry narrative that “there’s no medical reason to tell…

mifepristone

Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: Unwanted Abortions, Unnecessary Abortions, Unsafe Abortions

The failure of abortion providers to support and undertake prospective longitudinal studies of a nationally representative sample of women contributes…

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image